Forbion European Acqui A -23FRBNWPreferred / convertible
13F holders, Q2 2026 (June 30)1holders
0new positions
0sold out
$0.29avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Forbion European Acqui A -23 (FRBNW) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holder was Farther Finance Advisors, LLC ($159).
- Company
- Forbion European Acqui A -23
- Filed as
- ENGENE THERAPEUTICS INC WT EXP 103128 (Q2 2026)
- CUSIP
- G3619H110
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Farther Finance Advisors, LLC | — | No change | 550 | $159 |
"% of holder's portfolio" is FRBNW's weight in each manager's 13F, not the share of Forbion European Acqui A -23 the manager owns.